A Phase 2 Study of Enzalutamide in Patients With High-risk Prostate Cancer Who Have Undergone Local Definitive Therapy With Radical Prostatectomy
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 19 Feb 2019 Status changed from active, no longer recruiting to completed.
- 10 Feb 2018 Results assessing safety and efficacy presented at the 2018 Genitourinary Cancers Symposium
- 13 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2019.